Back

The association between LDL-C reduction and new events of diabetes and AMI during PCSK9 inhibitor treatment: A meta-analysis

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Lipids Lipids (Epidemiology and Prevention) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Christian Lewinter

Karolinska Institute, Stockholm (Sweden)

14 More presentations in this session

Presentation thumbnail
Associations between very low concentrations of LDL-cholesterol and health outcomes in the reasons for geographical and racial differences in stroke (REGARDS) Study
Professor P. Penson (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Cholesterol efflux capacity and incident atherosclerotic cardiovascular disease events in a Japanese general population
Doctor M. Ogura (Urayasu, JP)
Abstract
Presentation thumbnail
Undertreatment of female patients in lipid-lowering for secondary prevention in Europe, Canada, South-Africa, Middle East and China: results of the dyslipidemia international study (dysis)
Doctor A. Gitt (Ludwigshafen, DE)
Abstract Slides
Presentation thumbnail
Comparison of plaque microstructures between two high-intensity statin therapies: rosuvastatin versus atorvastatin
Doctor S. Honda (Osaka, JP)
Abstract
Presentation thumbnail
Sex-related differences in clinical characteristics, low-density lipoprotein cholesterol control and cardiovascular outcomes in familial hypercholesterolemia.
Doctor T. Doi (Herlev, DK)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Lipids

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources